rs28722602
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000355432.8(CSF2RA):c.1073G>A(p.Arg358Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0121 in 1,613,780 control chromosomes in the GnomAD database, including 195 homozygotes. There are 10,195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R358L) has been classified as Likely benign.
Frequency
Consequence
ENST00000355432.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.*49G>A | 3_prime_UTR_variant | 13/13 | ENST00000381529.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.*49G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_172245.4 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00916 AC: 1393AN: 152074Hom.: 9 Cov.: 33 AF XY: 0.00946 AC XY: 703AN XY: 74292
GnomAD3 exomes AF: 0.0116 AC: 2901AN: 251160Hom.: 36 AF XY: 0.0131 AC XY: 1778AN XY: 135722
GnomAD4 exome AF: 0.0124 AC: 18193AN: 1461588Hom.: 186 Cov.: 33 AF XY: 0.0131 AC XY: 9492AN XY: 727078
GnomAD4 genome ? AF: 0.00915 AC: 1392AN: 152192Hom.: 9 Cov.: 33 AF XY: 0.00945 AC XY: 703AN XY: 74420
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2022 | p.Arg358Gln in exon 11 of CSF2RA: This variant is not expected to have clinical significance because it has been identified in 3% (927/30780) of South Asian chromosomes, including 17 homozygotes and 1.2% (1538/128868) of European chromosomes, including 13 homozygotes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1; BP4. - |
CSF2RA-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at